Phosphorylation of ΔNp63α via a Novel TGFβ/ALK5 Signaling Mechanism Mediates the Anti-Clonogenic Effects of TGFβ

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Cherukuri, Pratima ^a   DeCastro, Andrew J ^a   Balboni, Amanda L ^a   Downey, Sondra L ^a   Liu, Jennifer Y ^b   Hutchinson, Justine A ^a   DiRenzo, James ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Lamont Doherty Earth Observatory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN DELTA NP63 ALPHA; PROTEIN P53; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG;

ARTICLE; BREAST EPITHELIUM; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL FRACTIONATION; COLONY FORMATION; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; PLASMID; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ULTRAVIOLET RADIATION;

CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; DNA PRIMERS; HUMANS; MODELS, BIOLOGICAL; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA; TUMOR SUPPRESSOR PROTEINS;

EID: 84869233597     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050066     Document Type: Article

References (53)

1. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, et al. (1998) p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2: 305-316.
2. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, et al. (1999) p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398: 708-713.
3. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, et al. (1999) p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398: 714-718.
4. Senoo M, Pinto F, Crum CP, McKeon F, (2007) p63 Is Essential for the Proliferative Potential of Stem Cells in Stratified Epithelia. Cell 129: 523-536.
5. Suh EK, Yang A, Kettenbach A, Bamberger C, Michaelis AH, et al. (2006) p63 protects the female germ line during meiotic arrest. Nature 444: 624-628.
6. Yang A, Zhu Z, Kapranov P, McKeon F, Church GM, et al. (2006) Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. Mol Cell 24: 593-602.
7. Rossi M, Aqeilan RI, Neale M, Candi E, Salomoni P, et al. (2006) The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc Natl Acad Sci U S A 103: 12753-12758.
8. Stehmeier P, Muller S, (2009) Regulation of p53 family members by the ubiquitin-like SUMO system. DNA Repair (Amst) 8: 491-498.
9. Jeon YJ, Jo MG, Yoo HM, Hong SH, Park JM, et al. (2012) Chemosensitivity is controlled by p63 modification with ubiquitin-like protein ISG15. J Clin Invest 122: 2622-2636.
10. Su X, Cho MS, Gi YJ, Ayanga BA, Sherr CJ, et al. (2009) Rescue of key features of the p63-null epithelial phenotype by inactivation of Ink4a and Arf. Embo J.
11. Jung MS, Yun J, Chae HD, Kim JM, Kim SC, et al. (2001) p53 and its homologues, p63 and p73, induce a replicative senescence through inactivation of NF-Y transcription factor. Oncogene 20: 5818-5825.
12. Keyes WM, Wu Y, Vogel H, Guo X, Lowe SW, et al. (2005) p63 deficiency activates a program of cellular senescence and leads to accelerated aging. Genes Dev 19: 1986-1999.
13. Keyes WM, Pecoraro M, Aranda V, Vernersson-Lindahl E, Li W, et al. (2011) DeltaNp63alpha is an oncogene that targets chromatin remodeler Lsh to drive skin stem cell proliferation and tumorigenesis. Cell Stem Cell 8: 164-176.
14. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, et al. (2012) The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data. Cancer Discov 2: 401-404.
15. Leong CO, Vidnovic N, DeYoung MP, Sgroi D, Ellisen LW, (2007) The p63/p73 network mediates chemosensitivity to cisplatin in a biologically defined subset of primary breast cancers. J Clin Invest 117: 1370-1380.
16. Rocco JW, Leong CO, Kuperwasser N, DeYoung MP, Ellisen LW, (2006) p63 mediates survival in squamous cell carcinoma by suppression of p73-dependent apoptosis. Cancer Cell 9: 45-56.
17. Kent S, Hutchinson J, Balboni A, Decastro A, Cherukuri P, et al. (2011) DeltaNp63alpha promotes cellular quiescence via induction and activation of Notch3. Cell Cycle 10: 3111-3118.
18. Ikushima H, Miyazono K, (2010) TGFbeta signalling: a complex web in cancer progression. Nat Rev Cancer 10: 415-424.
19. Schmierer B, Hill CS, (2007) TGFbeta-SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8: 970-982.
20. Attisano L, Carcamo J, Ventura F, Weis FM, Massague J, et al. (1993) Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 75: 671-680.
21. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, et al. (1992) TGF beta signals through a heteromeric protein kinase receptor complex. Cell 71: 1003-1014.
22. Guo X, Wang XF, (2009) Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res 19: 71-88.
23. Wakefield LM, Piek E, Bottinger EP, (2001) TGF-beta signaling in mammary gland development and tumorigenesis. J Mammary Gland Biol Neoplasia 6: 67-82.
24. Mullen AC, Orlando DA, Newman JJ, Loven J, Kumar RM, et al. (2011) Master transcription factors determine cell-type-specific responses to TGF-beta signaling. Cell 147: 565-576.
25. Parvani JG, Taylor MA, Schiemann WP, (2011) Noncanonical TGF-beta signaling during mammary tumorigenesis. J Mammary Gland Biol Neoplasia 16: 127-146.
26. Di Costanzo A, Festa L, Duverger O, Vivo M, Guerrini L, et al. (2009) Homeodomain protein Dlx3 induces phosphorylation-dependent p63 degradation. Cell Cycle 8: 1185-1195.
27. Komatsu S, Takenobu H, Ozaki T, Ando K, Koida N, et al. (2009) Plk1 regulates liver tumor cell death by phosphorylation of TAp63. Oncogene 28: 3631-3641.
28. Suzuki D, Senoo M (2012) Increased p63 Phosphorylation Marks Early Transition of Epidermal Stem Cells to Progenitors. J Invest Dermatol.
29. Westfall MD, Joyner AS, Barbieri CE, Livingstone M, Pietenpol JA, (2005) Ultraviolet radiation induces phosphorylation and ubiquitin-mediated degradation of DeltaNp63alpha. Cell Cycle 4: 710-716.
30. Yuan M, Luong P, Hudson C, Gudmundsdottir K, Basu S, (2010) c-Abl phosphorylation of DeltaNp63alpha is critical for cell viability. Cell Death Dis 1: e16.
31. Lazzari C, Prodosmo A, Siepi F, Rinaldo C, Galli F, et al. (2011) HIPK2 phosphorylates DeltaNp63alpha and promotes its degradation in response to DNA damage. Oncogene 30: 4802-4813.
32. DiRenzo J, Signoretti S, Nakamura N, Rivera-Gonzalez R, Sellers W, et al. (2002) Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. Cancer Res 62: 89-98.
33. Harmes DC, Bresnick E, Lubin EA, Watson JK, Heim KE, et al. (2003) Positive and negative regulation of deltaN-p63 promoter activity by p53 and deltaN-p63-alpha contributes to differential regulation of p53 target genes. Oncogene 22: 7607-7616.
34. Feng XH, Derynck R, (1996) Ligand-independent activation of transforming growth factor (TGF) beta signaling pathways by heteromeric cytoplasmic domains of TGF-beta receptors. J Biol Chem 271: 13123-13129.
35. Wieser R, Wrana JL, Massague J, (1995) GS domain mutations that constitutively activate T beta R-I, the downstream signaling component in the TGF-beta receptor complex. Embo J 14: 2199-2208.
36. Tojo M, Hamashima Y, Hanyu A, Kajimoto T, Saitoh M, et al. (2005) The ALK-5 inhibitor A-83-01 inhibits Smad signaling and epithelial-to-mesenchymal transition by transforming growth factor-beta. Cancer Sci 96: 791-800.
37. Ozdamar B, Bose R, Barrios-Rodiles M, Wang HR, Zhang Y, et al. (2005) Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307: 1603-1609.
38. Gambichler T, Tomi NS, Skrygan M, Altmeyer P, Kreuter A, (2006) Alterations of TGF-beta/Smad mRNA expression in atopic dermatitis following narrow-band ultraviolet B phototherapy: results of a pilot study. J Dermatol Sci 44: 56-58.
39. Lee HS, Kooshesh F, Sauder DN, Kondo S, (1997) Modulation of TGF-beta 1 production from human keratinocytes by UVB. Exp Dermatol 6: 105-110.
40. Yin L, Morita A, Tsuji T, (2003) The crucial role of TGF-beta in the age-related alterations induced by ultraviolet A irradiation. J Invest Dermatol 120: 703-705.
41. Biswas S, Guix M, Rinehart C, Dugger TC, Chytil A, et al. (2007) Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression. J Clin Invest 117: 1305-1313.
42. Nguyen DH, Oketch-Rabah HA, Illa-Bochaca I, Geyer FC, Reis-Filho JS, et al. (2011) Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer Cell 19: 640-651.
43. Javelaud D, Alexaki VI, Dennler S, Mohammad KS, Guise TA, et al. (2011) TGF-beta/SMAD/GLI2 signaling axis in cancer progression and metastasis. Cancer Res 71: 5606-5610.
44. Munger JS, Sheppard D, (2011) Cross talk among TGF-beta signaling pathways, integrins, and the extracellular matrix. Cold Spring Harb Perspect Biol 3: a005017.
45. Reiner JE, Datta PK, (2011) TGF-beta-dependent and-independent roles of STRAP in cancer. Front Biosci 16: 105-115.
46. Zwaagstra JC, Guimond A, O'Connor-McCourt MD, (2000) Predominant intracellular localization of the type I transforming growth factor-beta receptor and increased nuclear accumulation after growth arrest. Exp Cell Res 258: 121-134.
47. Li N, Singh S, Cherukuri P, Li H, Yuan Z, et al. (2008) Reciprocal intraepithelial interactions between TP63 and hedgehog signaling regulate quiescence and activation of progenitor elaboration by mammary stem cells. Stem Cells 26: 1253-1264.
48. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, et al. (2007) ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical Outcome. Cell Stem Cell 1: 555-567.
49. Cipriano R, Kan CE, Graham J, Danielpour D, Stampfer M, et al. (2011) TGF-beta signaling engages an ATM-CHK2-p53-independent RAS-induced senescence and prevents malignant transformation in human mammary epithelial cells. Proc Natl Acad Sci U S A 108: 8668-8673.
50. Lindsay J, McDade SS, Pickard A, McCloskey KD, McCance DJ, (2011) Role of DeltaNp63gamma in epithelial to mesenchymal transition. J Biol Chem 286: 3915-3924.
51. Higashikawa K, Yoneda S, Tobiume K, Taki M, Shigeishi H, et al. (2007) Snail-induced down-regulation of DeltaNp63alpha acquires invasive phenotype of human squamous cell carcinoma. Cancer Res 67: 9207-9213.
52. Anderton MJ, Mellor HR, Bell A, Sadler C, Pass M, et al. (2011) Induction of heart valve lesions by small-molecule ALK5 inhibitors. Toxicol Pathol 39: 916-924.
53. Mu Y, Sundar R, Thakur N, Ekman M, Gudey SK, et al. (2011) TRAF6 ubiquitinates TGFbeta type I receptor to promote its cleavage and nuclear translocation in cancer. Nat Commun 2: 330.